According to a study published in The Lancet Public Health journal, nearly all countries are overusing powerful “watch” antibiotics that contribute the most to antibiotic resistance, while many nations simultaneously fail to provide patients with life-saving “reserve” drugs. Researchers from institutions including the University of London developed a new framework assessing appropriate usage based on peer clusters, finding that 99 percent of analyzed countries exceeded expected consumption of watch-class medications.
Global Antibiotic Overuse Outpaces WHO Guidelines
The World Health Organization (WHO) sorts antibiotics into three categories: access, watch, and reserve. Access drugs, such as amoxicillin, serve as primary treatments for everyday infections. Watch medications are stronger agents reserved for conditions where simpler antibiotics won’t work, while reserve drugs act as a last resort against the most dangerous drug-resistant infections. A United Nations General Assembly agreement set a goal for 2030 stating that at least 70 percent of global antibiotic use must come from the access category. Researchers calculated that 77 percent of consumed courses should ideally belong to this group, making the UN target reasonable.
Real-world data analyzed from the IQVIA MIDAS database revealed a different reality across 67 countries, territories, and areas. The study’s authors noted that 72 percent of these regions consumed higher total antibiotic volumes than expected. Furthermore, 99 percent exceeded expected consumption levels for watch-class drugs. Simultaneously, more than half of the analyzed territories failed to utilize enough reserve antibiotics, meaning patients with life-threatening drug-resistant infections might not be receiving the treatments they need.
Peer Cluster Framework Exposes Country-Level Disparities
To evaluate whether individual countries use appropriate volumes, researchers built a framework organizing nations into peer clusters. These clusters group regions by shared traits like poverty levels, rates of infectious disease, and antibiotic resistance. The team estimated that the world needed roughly 43 billion antibiotic courses in 2019 to treat bacterial infections, averaging about one course per person annually. Low and middle-income nations carry heavier burdens of infectious disease and drug resistance, requiring proportionally higher amounts of specialized watch and reserve drugs. Despite this need, higher-income countries currently consume these types of antibiotics the most.
Did you know?
The WHO Access, Watch, Reserve (AWaRe) system is designed to form the basis for global antibiotic surveillance.
The study highlights specific nation-level metrics to demonstrate the gap between ideal and actual consumption. For instance, India—placed in cluster two—had an estimated optimal total defined daily doses per 1,000 inhabitants per day (DID) ranging between 9.9 and 14.7. However, the actual recorded DID reached 18.3. Watch antibiotics formed the major part of India’s actual consumption at 9.3 DID, while access antibiotics stood at 4.5 DID. Additionally, the study found that 60 percent of the evaluated countries still use antibiotics that the WHO considers should no longer be prescribed.
Frequently Asked Questions
What are “watch” antibiotics?
Watch antibiotics are stronger pharmaceutical agents that contribute the most to antibiotic resistance when overused. The WHO recommends saving them for conditions where simpler antibiotics won’t work.
Why is the UN targeting 70 percent access use?
The UN General Assembly agreed that by 2030, at least 70 percent of global antibiotic consumption should come from the access group.
Are low-income countries using too many antibiotics?
According to the study, low and middle-income nations face heavier burdens of infectious disease and drug resistance and need proportionally more of the specialised watch and reserve antibiotics, whereas higher-income countries currently use these types of antibiotics the most.
What are your thoughts on global antibiotic stewardship policies? Share this article on social media or subscribe to our newsletter for ongoing updates on public health research.
Related reading